These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 3169159)
1. Culture of putative Langerhans cell bone marrow precursors: characterization of their phenotype. de Fraissinette A; Schmitt D; Dezutter-Dambuyant C; Guyotat D; Zabot MT; Thivolet J Exp Hematol; 1988 Oct; 16(9):764-8. PubMed ID: 3169159 [TBL] [Abstract][Full Text] [Related]
2. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. Szabolcs P; Moore MA; Young JW J Immunol; 1995 Jun; 154(11):5851-61. PubMed ID: 7538534 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. Meunier L; Gonzalez-Ramos A; Cooper KD J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386 [TBL] [Abstract][Full Text] [Related]
5. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Smith SL; Bender JG; Maples PB; Unverzagt K; Schilling M; Lum L; Williams S; Van Epps DE Exp Hematol; 1993 Jul; 21(7):870-7. PubMed ID: 7686502 [TBL] [Abstract][Full Text] [Related]
6. The effect of recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor on Fc gamma receptor expression and antibody-dependent cellular cytotoxicity of hematopoietic progenitor cells during in vitro myeloid maturation. Ericson SG; Benoit NE; Mills LE; Fanger MW Exp Hematol; 1994 Mar; 22(3):283-9. PubMed ID: 7509291 [TBL] [Abstract][Full Text] [Related]
7. Ontogeny of Langerhans cells: phenotypic differentiation from the bone marrow to the skin. de Fraissinette A; Dezutter-Dambuyant C; Schmitt D; Thivolet J Dev Comp Immunol; 1990; 14(3):335-46. PubMed ID: 1698667 [TBL] [Abstract][Full Text] [Related]
8. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood. Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347 [TBL] [Abstract][Full Text] [Related]
10. Long-term culture of human bone marrow macrophages: macrophage development is associated with the production of granulomonopoietic enhancing activity (GM-EA). Wang SY; Castro-Malaspina H; Moore MA J Immunol; 1985 Aug; 135(2):1186-93. PubMed ID: 3891852 [TBL] [Abstract][Full Text] [Related]
11. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558 [TBL] [Abstract][Full Text] [Related]
12. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells. Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347 [TBL] [Abstract][Full Text] [Related]
13. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM; Gulati SC Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [TBL] [Abstract][Full Text] [Related]
14. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes. Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354 [TBL] [Abstract][Full Text] [Related]
15. Flow cytometric characterization of perfused human bone marrow cultures: identification of the major cell lineages and correlation with the CFU-GM assay. Brott DA; Maher RJ; Parrish CR; Richardson RJ; Smith AK Cytometry A; 2003 May; 53(1):22-7. PubMed ID: 12701129 [TBL] [Abstract][Full Text] [Related]
16. Enrichment of human marrow T-cell precursors by complement-dependent cytotoxicity with monoclonal antibodies and Percoll Gradient centrifugation. Ahmad M; de Laforest PG; Janossy G; Tanzer J Exp Hematol; 1987 Nov; 15(10):1035-40. PubMed ID: 3499336 [TBL] [Abstract][Full Text] [Related]
17. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Bernhard H; Disis ML; Heimfeld S; Hand S; Gralow JR; Cheever MA Cancer Res; 1995 Mar; 55(5):1099-104. PubMed ID: 7532543 [TBL] [Abstract][Full Text] [Related]
18. A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. Ito T; Inaba M; Inaba K; Toki J; Sogo S; Iguchi T; Adachi Y; Yamaguchi K; Amakawa R; Valladeau J; Saeland S; Fukuhara S; Ikehara S J Immunol; 1999 Aug; 163(3):1409-19. PubMed ID: 10415041 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver. Roy V; Miller JS; Verfaillie CM Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060 [TBL] [Abstract][Full Text] [Related]
20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation. Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]